Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NIMA related kinase 7 (NEK7) is a serine/threonine protein kinase and a member of the NIMA (never in mitosis gene a)-related kinase family. It plays essential roles in mitotic cell cycle progression, microtubule nucleation, mitotic spindle formation, cytokinesis, and NLRP3 inflammasome activation. It's involved in various diseases including Alzheimer’s disease, coronary atherosclerosis, diabetes mellitus type II, Muckle-Wells syndrome, and familial cold autoinflammatory syndrome. NEK7 represents an attractive target for therapeutic intervention against cancers characterized by abnormal proliferation or inflammatory diseases driven by aberrant inflammasome activation.
Small molecule inhibitors targeting catalytic site or regulatory interactions within cell division or inflammasome pathways.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on NIMA related kinase 7 (None).